Author: manuel.haymoz
Health Tech Networking Reception in San Francisco
Business Location Switzerland, together with the Swiss American Chamber of Commerce San Francisco Chapter, will be hosting a health tech networking reception in San Francisco. Join us for a night of networking with US and Swiss life science executives and enjoy the beautiful view of the Bay Bridge over complimentary drinks and hors d’oeuvres in […]
August 16, 2023
What can artificial intelligence do for health?
Algorithms help diagnose and treat diseases, discover new drugs and personalize prevention. Thus, the potential of artificial intelligence has been recognized not only by the medtech industry but also by health systems, pharmaceutical companies, patients and even the World Health Organization. What’s the state of artificial intelligence in healthcare? In 2009, Hiroshi Kobayashi, a scientist […]
January 11, 2023
CHUV, CERN and THERYQ join forces for a world first in cancer radiotherapy
CHUV, CERN and THERYQ will develop a revolutionary FLASH radiotherapy device to treat cancers resistant to conventional treatments. The Centre Hospitalier Universitaire Vaudois (CHUV), the European Laboratory for Particle Physics (CERN) and THERYQ (ALCEN Group) have signed an agreement for the world-first development of a revolutionary FLASH radiotherapy device that will use very high energy […]
January 11, 2023
BioFi AG newly settles in Basel
BioFi has set up its headquarters in Basel. The company has emerged from Crowley Davis Research, which was established in the US state of Idaho in 2000. Using its proprietary technologies, BioFi operates the CellSim platform, which can be used to model and simulate living organisms. The newly established company BioFi AG has settled in Basel. It […]
January 11, 2023
Novartis investing 100 million Swiss francs in new biologics center
The pharmaceutical company Novartis is investing a sum of 100 million Swiss francs in a new competence center for biologics at its Basel campus. Here, the aim will be to accelerate the development of highly effective drugs as part of collaborative projects with scientists. The Basel-based pharmaceutical company Novartis is investing a total of 100 million […]
January 11, 2023
Artificial intelligence to improve cancer diagnosis
As part of the European BigPicture project, Henning Müller and his team from the HES-SO Valais in Sierre are developing algorithms to improve cancer diagnosis. These technologies are of interest to certain hospitals, including Sion. Since February 2021, Henning Müller, head of the eHealth Unit at the Computer Science Institute of the HES-SO Valais-Wallis in Sierre, has […]
January 11, 2023